Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

2007792 citationsJournal Articlebronze Open Access

Authors

James B. Bussel · Cornell University

Gregory Cheng · Prince of Wales Hospital

Mansoor N. Saleh · Georgia Cancer Specialists

Bethan Psaila · Cornell University

Lidia Kovaleva · Endocrinology Research Center

Balkis Meddeb · GlaxoSmithKline (United Kingdom)

Janusz Kłoczko ·

Abstract

Eltrombopag increased platelet counts in a dose-dependent manner in patients with relapsed or refractory ITP. (ClinicalTrials.gov number, NCT00102739.)

Topics & Keywords

Platelet Disorders and Treatments Blood groups and transfusion Blood properties and coagulation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 357, Issue 22, pp. 2237-2247

DOI: 10.1056/nejmoa073275

Field-Weighted Citation Impact: 29.75